2025 ICD-10-CM code J70.2
(Active) Effective Date: N/A Diseases of the respiratory system - Lung diseases due to external agents 10 Feed
Acute drug-induced interstitial lung disorders.
Medical necessity for treatment and management of acute drug-induced interstitial lung disorder is established by the severity of symptoms, impact on respiratory function, and potential for complications.
The physician is responsible for diagnosing the acute drug-induced interstitial lung disorder, determining the causative medication, and initiating appropriate treatment and management.
In simple words: This code refers to a sudden inflammation and scarring within the lungs caused by certain medications.
Acute drug-induced interstitial lung disorders. Use additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).
Example 1: A patient presents with acute respiratory distress after starting a new medication. Imaging and other tests reveal interstitial lung changes, and the diagnosis of acute drug-induced interstitial lung disorder is made., A patient undergoing chemotherapy develops sudden onset shortness of breath and cough. A chest CT scan shows interstitial lung disease, attributed to the chemotherapy drug., A patient with a history of rheumatoid arthritis develops rapid-onset lung problems after taking methotrexate. The diagnosis is acute drug-induced interstitial lung disorder, and the medication is discontinued.
Documentation should include the type and duration of symptoms, medication history, imaging results (e.g., chest x-ray, CT scan), pulmonary function tests, and other relevant clinical findings supporting the diagnosis.
- Specialties:Pulmonology, Internal Medicine, Critical Care Medicine, Oncology
- Place of Service:Inpatient Hospital, On Campus-Outpatient Hospital, Office